GPT and metabolic dysfunction-associated steatotic liver disease: Noninvasive fibrosis scoring systems; including fibrosis-4 (FIB-4); NAFLD fibrosis score (NFS); BMI, AST/ALT ratio (BARD) score; and AST-to-platelet ratio index; have all been validated in MASLD [42,58].